AGEL cleared with conditions to take sole control of Lučenec hospital

Slovakia's Antimonopoly Office approved on 7 September 2026, subject to conditions, the concentration by which AGEL SK a.s. of Bratislava acquires sole control over Všeobecná nemocnica s poliklinikou, n.o., Lučenec; the announcement was published on 14 September. The case was preceded by extensive pre-notification contacts in which the scope of information needed was discussed, a market survey was carried out — including the views of health insurers and hospitals — and, following a preliminary identification of competition concerns, the draft conditions themselves were consulted. The AGEL group operates in Slovakia in inpatient and outpatient care, diagnostic and treatment units, pharmacy care, patient transport and occupational health; the Lučenec hospital provides inpatient, outpatient, diagnostic and transport services. The office examined the overlap primarily in the Banská Bystrica self-governing region, including the group's position with respect to medical staff, its relationships in supplier and customer markets, and its strength in dealings with health insurers.